ACONW - Aclarion, Inc.

0.0326
-0.001   -2.761%

Share volume: 2,561
Last Updated: 05-12-2026
Healthcare/Services – Health: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.03
0.00
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 43%
Dept financing 24%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.40%
1 Month
-11.65%
3 Months
-4.12%
6 Months
-24.54%
1 Year
12.03%
2 Year
-14.21%
Key data
Stock price
$0.03
P/E Ratio 
0.00
DAY RANGE
$0.03 - $0.03
EPS 
-$12.55
52 WEEK RANGE
$0.02 - $0.23
52 WEEK CHANGE
$11.26
MARKET CAP 
4.368 M
YIELD 
N/A
SHARES OUTSTANDING 
671.371 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.49
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,333
AVERAGE 30 VOLUME 
$5,456
Company detail
CEO: Brent Ness
Region: US
Website: aclarion.com
Employees: 7
IPO year: 2022
Issue type:
Market: NASDAQ
Industry: Healthcare/Services – Health
Sector: Services

Aclarion, Inc. develops software application for magnetic resonance spectroscopy (MRS) in the U.S. It offers NOCISCAN-LS Post-Processor suite, NOCICALC-LS, and NOCIGRAM-LS. The company was formerly known as Nocimed, which changed its name to ACLarion in December 2021.

Recent news